GeoVax Labs (GOVX) Short term Debt (2010 - 2020)
GeoVax Labs (GOVX) posted quarterly Short term Debt of $435711.0 for Q2 2020, up 756.42% quarter-over-quarter from $50876.0 in Q2 2016.
GeoVax Labs (GOVX) Short term Debt (2010 - 2020) Analysis & Trends
GeoVax Labs (GOVX) has reported Short term Debt for 8 consecutive years, with $435711.0 the latest figure, recorded in Q2 2020.
- In Q2 2020, Short term Debt changed N/A year-over-year to $435711.0; the TTM figure through Jun 2020 stood at $435711.0 (changed N/A YoY), while the FY2015 annual figure was $22000.0, down 72.12% from the prior year.
- Short term Debt grew to $435711.0 in Q2 2020 per GOVX's latest filing, from $50876.0 in the prior quarter.
- Across five years, Short term Debt topped out at $435711.0 in Q2 2020 and bottomed at $35000.0 in Q1 2016.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.69 Bn | 131.84 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 86.54 Bn | 78.54 Bn | 3.93 Bn |
| 3 | Argenx Se | 65.27 Bn | 60.09 Bn | 1.37 Bn |
| 4 | Moderna | 59.41 Bn | 54.27 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 42.12 Bn | 37.02 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.80 Bn | 28.49 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.07 Bn | 9.68 Bn | 668.28 Mn |
| 8 | Insmed | 27.55 Bn | 26.39 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.28 Bn | 26.44 Bn | - |
| 10 | GeoVax Labs | 2.88 Mn | -267,341.61 | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2020 | 435,711.00 |
| Jun 30, 2016 | 50,876.00 |
| Mar 31, 2016 | 35,000.00 |
| Dec 31, 2015 | 22,000.00 |
| Sep 30, 2015 | 70,729.00 |
| Jun 30, 2015 | 57,048.00 |
| Mar 31, 2015 | 102,638.00 |
| Dec 31, 2014 | 78,917.00 |
| Sep 30, 2014 | 79,757.00 |
| Jun 30, 2014 | 111,200.00 |
| Mar 31, 2014 | 87,042.00 |
| Dec 31, 2013 | 60,000.00 |
| Sep 30, 2013 | 20,225.00 |
| Jun 30, 2013 | 25,000.00 |
| Mar 31, 2013 | 209,520.00 |
| Dec 31, 2012 | 129,370.00 |
| Sep 30, 2012 | 166,176.00 |
| Jun 30, 2012 | 275,668.00 |
| Mar 31, 2012 | 292,958.00 |
| Dec 31, 2011 | 677,327.00 |